249 related articles for article (PubMed ID: 34593029)
1. Loss of presenilin function enhances tau phosphorylation and aggregation in mice.
Soto-Faguás CM; Sanchez-Molina P; Saura CA
Acta Neuropathol Commun; 2021 Sep; 9(1):162. PubMed ID: 34593029
[TBL] [Abstract][Full Text] [Related]
2. Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system.
Tackenberg C; Kulic L; Nitsch RM
PLoS One; 2020; 15(9):e0239584. PubMed ID: 32966331
[TBL] [Abstract][Full Text] [Related]
3. Partial loss of presenilin impairs age-dependent neuronal survival in the cerebral cortex.
Watanabe H; Iqbal M; Zheng J; Wines-Samuelson M; Shen J
J Neurosci; 2014 Nov; 34(48):15912-22. PubMed ID: 25429133
[TBL] [Abstract][Full Text] [Related]
4. The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism.
Shen J; Kelleher RJ
Proc Natl Acad Sci U S A; 2007 Jan; 104(2):403-9. PubMed ID: 17197420
[TBL] [Abstract][Full Text] [Related]
5. APP/PS1 mice overexpressing SREBP-2 exhibit combined Aβ accumulation and tau pathology underlying Alzheimer's disease.
Barbero-Camps E; Fernández A; Martínez L; Fernández-Checa JC; Colell A
Hum Mol Genet; 2013 Sep; 22(17):3460-76. PubMed ID: 23648430
[TBL] [Abstract][Full Text] [Related]
6. Variations in the neuropathology of familial Alzheimer's disease.
Shepherd C; McCann H; Halliday GM
Acta Neuropathol; 2009 Jul; 118(1):37-52. PubMed ID: 19306098
[TBL] [Abstract][Full Text] [Related]
7. Formation of tau inclusions in knock-in mice with familial Alzheimer disease (FAD) mutation of presenilin 1 (PS1).
Tanemura K; Chui DH; Fukuda T; Murayama M; Park JM; Akagi T; Tatebayashi Y; Miyasaka T; Kimura T; Hashikawa T; Nakano Y; Kudo T; Takeda M; Takashima A
J Biol Chem; 2006 Feb; 281(8):5037-41. PubMed ID: 16377636
[TBL] [Abstract][Full Text] [Related]
8. Convergence of presenilin- and tau-mediated pathways on axonal trafficking and neuronal function.
Peethumnongsin E; Yang L; Kallhoff-Muñoz V; Hu L; Takashima A; Pautler RG; Zheng H
J Neurosci; 2010 Oct; 30(40):13409-18. PubMed ID: 20926667
[TBL] [Abstract][Full Text] [Related]
9. Presenilin transgenic mice as models of Alzheimer's disease.
Elder GA; Gama Sosa MA; De Gasperi R; Dickstein DL; Hof PR
Brain Struct Funct; 2010 Mar; 214(2-3):127-43. PubMed ID: 19921519
[TBL] [Abstract][Full Text] [Related]
10. Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease.
Saul A; Sprenger F; Bayer TA; Wirths O
Neurobiol Aging; 2013 Nov; 34(11):2564-73. PubMed ID: 23747045
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Early Growth Response 1 in the Hippocampus Alleviates Neuropathology and Improves Cognition in an Alzheimer Model with Plaques and Tangles.
Qin X; Wang Y; Paudel HK
Am J Pathol; 2017 Aug; 187(8):1828-1847. PubMed ID: 28641077
[TBL] [Abstract][Full Text] [Related]
12. A three-dimensional human neural cell culture model of Alzheimer's disease.
Choi SH; Kim YH; Hebisch M; Sliwinski C; Lee S; D'Avanzo C; Chen H; Hooli B; Asselin C; Muffat J; Klee JB; Zhang C; Wainger BJ; Peitz M; Kovacs DM; Woolf CJ; Wagner SL; Tanzi RE; Kim DY
Nature; 2014 Nov; 515(7526):274-8. PubMed ID: 25307057
[TBL] [Abstract][Full Text] [Related]
13. Selective expression of the neurexin substrate for presenilin in the adult forebrain causes deficits in associative memory and presynaptic plasticity.
Sánchez-Hidalgo AC; Arias-Aragón F; Romero-Barragán MT; Martín-Cuevas C; Delgado-García JM; Martinez-Mir A; Scholl FG
Exp Neurol; 2022 Jan; 347():113896. PubMed ID: 34662541
[TBL] [Abstract][Full Text] [Related]
14. Death-associated protein kinase 1 mediates Aβ42 aggregation-induced neuronal apoptosis and tau dysregulation in Alzheimer's disease.
Zhang T; Xia Y; Hu L; Chen D; Gan CL; Wang L; Mei Y; Lan G; Shui X; Tian Y; Li R; Zhang M; Lee TH
Int J Biol Sci; 2022; 18(2):693-706. PubMed ID: 35002518
[TBL] [Abstract][Full Text] [Related]
15. TDP-43 expression influences amyloidβ plaque deposition and tau aggregation.
Davis SA; Gan KA; Dowell JA; Cairns NJ; Gitcho MA
Neurobiol Dis; 2017 Jul; 103():154-162. PubMed ID: 28416393
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.
Schweig JE; Yao H; Beaulieu-Abdelahad D; Ait-Ghezala G; Mouzon B; Crawford F; Mullan M; Paris D
Acta Neuropathol Commun; 2017 Sep; 5(1):69. PubMed ID: 28877763
[TBL] [Abstract][Full Text] [Related]
17. Hyperphosphorylated tau and paired helical filament-like structures in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes.
Kurt MA; Davies DC; Kidd M; Duff K; Howlett DR
Neurobiol Dis; 2003 Oct; 14(1):89-97. PubMed ID: 13678670
[TBL] [Abstract][Full Text] [Related]
18. Presenilin/γ-secretase regulates neurexin processing at synapses.
Saura CA; Servián-Morilla E; Scholl FG
PLoS One; 2011 Apr; 6(4):e19430. PubMed ID: 21559374
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity.
Sevalle J; Ayral E; Hernandez JF; Martinez J; Checler F
J Neurochem; 2009 Jul; 110(1):275-83. PubMed ID: 19457123
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1.
Boutajangout A; Authelet M; Blanchard V; Touchet N; Tremp G; Pradier L; Brion JP
Neurobiol Dis; 2004 Feb; 15(1):47-60. PubMed ID: 14751770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
